Dr. Rodgers previously served as chief technology officer of BioProcessors from 2002 to 2009. He evaluated market opportunities and then recruited and led a highly talented team of scientists and engineers to develop the SimCell technology for high throughput cell culture experimentation. This technology enables multi-factorial experimentation with a 20 to 50 fold improvement in throughput over conventional methods. While CTO at BioProcessors, he established scientific collaborations with key customers and played an active role in raising over $30 million of venture capital funding. He has also originated numerous grants and fee-for service research projects.
Prior to 2002, Dr. Rodgers was employed by McKinsey & Company, where he served as a consultant to a diverse group of Fortune 500 companies. He focused on strategy and business building in the chemicals, logistics and technology sectors. Dr. Rodgers holds Ph.D. and M.S degrees in Chemical Engineering from Massachusetts Institute of Technology, where his research focused on analysis and design of reactors for chemical vapor deposition and plasma etching processes. He also holds a B.S. (magna cum laude) from University of California San Diego.
